Milestone Pharmaceuticals (MIST) Tax Provisions (2018 - 2020)
Milestone Pharmaceuticals' (MIST) quarterly Tax Provisions came in at -$17000.0 in Q3 2020, up 76.71% on a YoY basis from -$9620.2 in Q4 2019, and down 1600.0% quarter-over-quarter from -$1000.0 in Q4 2019.
Analysis
Milestone Pharmaceuticals (MIST) Tax Provisions (2018 - 2020) Analysis & Trends
Milestone Pharmaceuticals (MIST) has reported Tax Provisions for 3 consecutive years, with -$17000.0 the latest figure, recorded in Q3 2020.
- For the quarter ending Q3 2020, Tax Provisions rose 76.71% year-over-year to -$17000.0; the trailing twelve-month figure through Dec 2020 stood at -$91000.0 (down 62.5% YoY), and the FY2020 full-year result was -$17000.0, up 69.64% from the prior year.
- Tax Provisions fell to -$17000.0 in Q3 2020 per MIST's latest filing, from -$1000.0 in the prior quarter.
- Across five years, Tax Provisions topped out at $56000.0 in Q4 2018 and bottomed at -$73000.0 in Q3 2019.
- Historically, Tax Provisions has averaged $125.0 across 3 years, with a median of $500.0 in 2018.
- The sharpest annual moves came in 2019 and 2020: Tax Provisions slumped 300.0% in 2019, then soared 76.71% in 2020.
- Over 3 years, Tax Provisions stood at $56000.0 in 2018, then slumped by 101.79% to -$1000.0 in 2019, then tumbled by 1600.0% to -$17000.0 in 2020.
- According to Business Quant data, Tax Provisions over the past three periods registered -$17000.0, -$1000.0, and -$73000.0 for Q3 2020, Q4 2019, and Q3 2019 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 393.00 Mn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 242.00 Mn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 292.00 Mn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 230.90 Mn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | -59.00 Mn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 15.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 13.31 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 34.90 Mn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | -3.96 Mn |
| 10 | Milestone Pharmaceuticals | 146.32 Mn | -25.18 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2020 | -17,000.00 |
| Dec 31, 2019 | -1,000.00 |
| Sep 30, 2019 | -73,000.00 |
| Jun 30, 2019 | -4,000.00 |
| Mar 31, 2019 | 22,000.00 |
| Dec 31, 2018 | 56,000.00 |
| Jun 30, 2018 | 2,000.00 |
| Mar 31, 2018 | 16,000.00 |